
Qtoglym 0.3/2 Tablet ER
Marketer
Shashvat Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Qtoglym 0.3/2 Tablet ER
Qtoglym 0.3/2 ER tablets are classified as antidiabetic medications, specifically a combination therapy for adult-onset type 2 diabetes. This medication assists in regulating blood glucose concentrations. Administer Qtoglym 0.3/2 ER tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar or feeling well; abrupt cessation may elevate glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. This medication is one component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, vertigo, cephalgia, and tremors. Prompt glucose intake (e.g., sugary foods, fruit juice) is essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential adverse effects encompass altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, visual blurring, fractures, and upper respiratory infections. Weight gain may also occur. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests to assess hematological parameters and liver function are recommended.
Uses of Qtoglym 0.3/2 Tablet ER
Managing type 2 diabetes
Major Benefits of Qtoglym 0.3/2 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Qtoglym 0.3/2 Tablet ER on an empty stomach.
Common Side effects of Qtoglym 0.3/2 Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Qtoglym 0.3/2 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. Administer Qtoglym 0.3/2 Tablet ER on an empty stomach.
How Qtoglym 0.3/2 Tablet ER works:
The extended-release tablet, Qtoglym 0.3/2, contains a triple-action formula for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Qtoglym 0.3/2 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Qtoglym 0.3/2 tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Qtoglym 0.3/2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The extended-release Qtoglym 0.3/2 Tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. A physician's consultation is advised. Furthermore, Qtoglym 0.3/2 Tablet ER is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Qtoglym 0.3/2 Tablet ER cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Qtoglym 0.3/2 Tablet ER therapy typically begins with a reduced dose; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Qtoglym 0.3/2 Tablet ER :
Should you forget to take a Qtoglym 0.3/2 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Qtoglym 0.3/2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
